Maybe Logo Early Access

Tools / Inside Trading Tracker

Inside Trading Tracker

Track insider trading activity at publicly traded companies to understand how executives are trading their shares.

    Accelerate Diagnostics Inc (AXDX) Insider Trading Activity

    Healthcare • Medical Devices • 134 employees

    Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.

    Total Value

    $9,345.25

    Total Shares

    515

    Average Trade Value

    $2,336.31

    Most Active Insider

    Schuler Jack W

    Total Activity: $314,000

    Largest Single Transaction

    $314,000

    by Schuler Jack W on Dec 3, 2024

    30-Day Activity

    2 Transactions

    Volume: 515 shares
    Value: $9,345

    Name
    Position
    Date
    Shares
    Value
    Holdings
    Type
    Chief Executive Officer
    Director, Officer
    Feb 3, 2025 485 $655 163,434 (-0.3%) Sale
    Chief Executive Officer
    Director, Officer
    Feb 1, 2025 1,000 $10,000 163,919 (+0.6%) Exercise/Conversion
    Director, 10% Owner
    Dec 3, 2024 200,000 $314,000 8,310,388 (-2.4%) Sale
    Director
    Dec 3, 2024 200,000 $314,000 653,224 (+30.6%) Purchase